Clinics and Practice (Oct 2021)

Analysis of the Delta Variant B.1.617.2 COVID-19

  • Shayan Shiehzadegan,
  • Nazanin Alaghemand,
  • Michael Fox,
  • Vishwanath Venketaraman

DOI
https://doi.org/10.3390/clinpract11040093
Journal volume & issue
Vol. 11, no. 4
pp. 778 – 784

Abstract

Read online

With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more contagious. One study has reported that the delta variant is 60% more transmissible than the alpha variant. As of August 2021, the delta variant has quickly become the dominant strain. Despite countries like the US, where most of the population is vaccinated, COVID-19 has made a resurgence in infections. Collectively, as a country, we ask: is it more deadly? What makes it more “contagious” or “transmissible”? This review article delves into the information we already know about the delta variant and how it compares with the other SARS-CoV-2 variants. The current vaccine companies like AstraZeneca, Pfizer/BioNTech, and Moderna have reported that their vaccines can provide protection against this variant but with a slightly reduced efficacy. In this article, we do a comprehensive review and summary of the delta B.1.617.2 variant and what makes it more contagious.

Keywords